BIO DESIGN LAB
Live / Registered — Registered (as of 16 Aug 2022)
What this means for you
Registered since 16 Aug 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79319092
- Registration number
- 6816963
- Mark type
- Design + words
- Filed
- 14 Jul 2021
- Published for opposition
- 31 May 2022
- Registered
- 16 Aug 2022
- Attorney of record
- Jong Park
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating metabolic disorders; vaccines against flu; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; pharmaceutical agents affecting digestive organs; stem cells for veterinary purposes; antibodies for veterinary purposes; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cardiovascular disease; allergy medications; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; medicines for the treatment of gastrointestinal diseases; nucleic acid sequences for medical and veterinary purposes; cells for medical purposes; reagents for use in medical genetic testing; diagnostic preparations for medical purposes; human immune globulin; pharmaceutical preparations for the treatment of auto-immune diseases; stem cells for medical purposes; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for diagnosis; anti-viral agents
Owner
Prosecution history
- 21 Dec 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 29 Nov 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 29 Nov 2022 — FINAL DISPOSITION PROCESSED
- 16 Nov 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 16 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
- 31 May 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 May 2022 — PUBLISHED FOR OPPOSITION
- 11 May 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 May 2022 — REFUSAL PROCESSED BY IB
- 28 Apr 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Apr 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 21 Apr 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Apr 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Apr 2022 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB